Spots Global Cancer Trial Database for Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE)
Official Title: Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors
Study ID: NCT01201096
Study Description
Brief Summary: The purpose of this study is to show the tumor free long term survival of patients with isolated non-resectable liver metastases of neuroendocrine tumors after neo-adjuvant radio receptor treatment and following liver transplantation.
Detailed Description: Matching patient will be treated neo-adjuvant at the hospital with 177 Lutetium peptide receptor radiotherapy in two following courses. After this treatment it will follow the liver transplantation within 9 month as postmortal or living donor liver transplantation. Under certain conditions concerning the evaluation examinations patients can be included in the study. Most important factors are no evidence of disease outside the liver, removed primary tumor, patients between 18 and 60 years, no curative surgical resection of the liver metastasis possible.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Center for neuroendokrine tumors, Zentralklinik Bad Berka, Bad Berka, Thüringen, Germany
Department of general-, visceral- and vascular surgery, University of Jena, Jena, Thüringen, Germany
Contact Details
Name: Christine Wurst, Dr. med.
Affiliation: Department of general-, visceral- and vascular surgery, University of Jena
Role: PRINCIPAL_INVESTIGATOR
Name: Dieter Hörsch, Prof. Dr. med
Affiliation: Zentrum für neuroendokrine Tumore, Zentralklinik Bad Berka
Role: STUDY_DIRECTOR
Name: Utz Settmacher, Prof. Dr. med.
Affiliation: Department of general-, visceral- and vascular surgery, University of Jena
Role: STUDY_CHAIR
Name: R. B. Baum, Prof.Dr.med.
Affiliation: Center of neuroendocrine tumors, Zentralklinik Bad Berka
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
